H
Loading...
Loading...
CDC PLACES does not publish a city-level diabetes row for Pittsburgh. Use the national 12% (CDC National Diabetes Statistics Report) plus your own panel — do not invent a local rate. Census population 302,971. Pennsylvania Medicare wound biologics: Novitas Solutions (JL). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Pittsburgh clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Pittsburgh storefront.
Build Your Biologic Treatment Center in Pittsburgh, PA for clinics & physicians. Start or expand your biol… Compliance support & pricing — contact Hawk Medical.
Pittsburgh is a city of 250k–500k (302,971 Census). CDC PLACES does not publish a city-level diabetes row for Pittsburgh. Use the national 12% (CDC National Diabetes Statistics Report) plus your own panel — do not invent a local rate. CDC PLACES does not publish an arthritis rate for Pittsburgh. Plan joint volume from your referral mix, not a made-up city figure. Keep 361 tissue, autologous PRP, and skin substitutes on different tickets. We onboard against that split — then ship.
National Build Your Biologic Treatment Center notes (how the product actually works)JL reviewers still want serial wound measurements and conservative-care history before CTPs, whether diabetes in Pittsburgh is unpublished at place grain or not. PLACES is planning data. The LCD is the claim.
Vendor consolidation is boring on purpose: one account, IFUs filed, JL articles mapped. We do not have a CDC PLACES uninsured rate for Pittsburgh. Expect a mix of JL fee-for-service, Advantage, workers’ comp, and cash-pay, and price them as separate tickets. Pricing scripts have to match that mix. We will help write them. We will not book your patients.
CDC PLACES has no incorporated-place row we could match for Pittsburgh. We will not interpolate one from the state BRFSS range. Use the national 12% (CDC) plus your panel.
No. Hawk Medical does not distribute products as “stem cell therapy.” HCT/P 361 allografts are regulated under 21 CFR 1271 for homologous use and minimal manipulation. PRP is autologous. Marketing that blurs those lanes is a compliance problem in every state, including Pennsylvania.
We distribute nationwide. Transit time depends on carrier and SKU, not on a fictional local warehouse. Ask for current lead times on the specific centrifuge, allograft, or CTP you intend to bill.
The 96.5% figure is a product-level clinical experience statistic published on our wound-care materials — not a city-specific trial. Your outcomes will depend on patient selection, offloading, and follow-up.
If you operate in Pennsylvania and another MAC state, say it on the first call. JL will not port 1:1. We would rather split utilization than watch a sister clinic copy Pittsburgh tickets into the wrong jurisdiction.
Contact us to learn how Hawk Medical supports practices in Pittsburgh, PA.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Pittsburgh is JL geography and published epidemiology — not a street address.
No PLACES city row. National CDC 12% is the floor until you use your own panel.
Pennsylvania Part B wound biologics follow this contractor (siblings: DC, DE, MD, NJ). We train to the articles. We do not write coverage.
City-proper population is scale for a city of 250k–500k, not a count of orthopedic groups.
No Pittsburgh storefront. Joe Bradley is an active practice owner. biologic treatment center stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.